HomeILMN • NASDAQ
add
Illumina Inc
Nakaraang pagsara
$112.77
Sakop ng araw
$114.25 - $119.68
Sakop ng taon
$89.00 - $213.91
Market cap
18.41B USD
Average na Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.08B | -1.01% |
Gastos sa pagpapatakbo | 763.00M | -0.65% |
Net na kita | -126.00M | -4,300.00% |
Net profit margin | -11.71 | -4,282.14% |
Kita sa bawat share | 0.09 | 12.50% |
EBITDA | 0.00 | -100.00% |
Aktuwal na % ng binabayarang buwis | -15.60% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.11B | -27.01% |
Kabuuang asset | 10.04B | -14.99% |
Kabuuang sagutin | 4.31B | -15.87% |
Kabuuang equity | 5.73B | — |
Natitirang share | 159.00M | — |
Presyo para makapag-book | 3.13 | — |
Return on assets | -1.19% | — |
Return on capital | -1.51% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -126.00M | -4,300.00% |
Cash mula sa mga operasyon | 77.00M | 670.00% |
Cash mula sa pag-invest | -48.00M | 14.29% |
Cash mula sa financing | 35.00M | 107.40% |
Net change in cash | 60.00M | 111.61% |
Malayang cash flow | 184.00M | 321.35% |
Tungkol
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
10,615
